Top Tweets for #Imdc
Proud of #IMDC Fellow Dr Heber Reyes-Garcia @heberolimus for presenting work on over 2000 patients treated with NIVO IPI for metastatic #kidneycancer. Conditional survival works and can inform patient prognosis further. @oncoalert #ASCO26
⭐ @ASCOTECAG Spotlight 👉 We are visiting @heberolimus Poster presentation 05/31 09:00 AM presenting @ASCO 1L Nivolumab/Ipilimumab for mRCC: Real-world benchmarking analysis from the IMDC at board 28. Congrats @ahs_media, @imdconline, @drdanielheng et al. 🎉
#ASCO26 @NazliDizman @Chris_PouliosMD @quantumonc @rohitbanwar @noha_soror @royaryam @heberolimus @IbrahimAzarOnc @Dr_Crazy94 @dominicandoc2 @OncoAlert @montypal @SPremji7866 @IMG_Oncologists @DrChoueiri @jrgralow @FionnualaCrowle @ja_ocejo @noha_soror @royaryam @OncoAlert @OncBrothers @crisbergerot @PauloBergerot @realbowtiedoc @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc @BHuffmanMD @AnaVManana @AmandaNizamMD
🎥 New on #OncologyBytes from #IUCS2025
Dr Sara Rebuzzi shares results from the Meet-URO 33 study in mRCC.
Watch here: https://t.co/60Z4aUEL2p
#RenalCellCarcinoma #mRCC #MeetURO #IMDC #Oncoassist #Oncoalert #IUCS2026 @urologysummit @gbanna74
I love our team! Thanks for representing at #GU25 in San Francisco. I love this conference. So much learning and connecting. @IMDConline #AmazingFellows @UCalgaryMed @albertacancer @asco #GU25 @Nimira_A @Yipilimumab @DrTakemura @DrJeffreyGraham @AudreylieL
Superb presentation by the one and only @Chrislabaki1 ! 1L IO provides survival benefit in sarc-RCC AND rhabdoid-RCC in nccRCC!
@DrDanielHeng #IMDC
Excellent presentation from the #IMDC superstar lead fellow @RazaneHChehade #RHC assessing low vs low-intermediate substrata of IMDC risk groups!
@DrDanielHeng @SylvanBacaLab @DanaFarber
Very interesting to see how this discussion has evolved over the past decade. I remember ~5y ago when the choice was largely between #CM214 & #KN426; at that time, the argument for #IMDC appeared to be much stronger, for good reason. Good to have @DrDanielHeng at #AUC3 to offer a counterpoint. @AlbigesL @crisuarez08 @motzermd @DrRosenbergMSK @BraunMDPhD @MVossMD @TiansterZhang @MVossMD
All the renal cancer panel #AUC3 feel IMDC should not be used to select patients for 1st line ipi/nivo therapy. Guidlines (NCCN/ESMO) support this (weak recommendation) @DrBradMcKay @DrChoueiri @TiansterZhang @montypal
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma - @EurUrolFocus
#IMDC stuff from @IMDConline folks @DrDanielHeng @DrRanaMcKay @RazaneHChehade @justinepanian https://t.co/qFFvTQ5B0o
Our new @IMDConline paper in @ESMO_Open led by @DrTakemura ! great job Kosuke and mentor @DrDanielHeng @albertacancer. cc: @DanaFarber_GU @DanaFarber @DanaFarberNews. Follow our @IMDConline website at: https://t.co/UQu7YZMmyv and get to know the #IMDC history with @DrDanielHeng
Just out @ESMO_Open Baseline lymphopenia (<1000 cells/μl) was found in 195/966 (20%) pts with metastatic #kidneycancer receiving IO combo and was associated with worse oncologic outcomes. Special thanks to @DrChoueiri @DrDanielHeng and other collaborators @IMDConline
@brian_rini @Uromigos presenting an impressive biomarker effort for KN-426 - overall, pembro+axis superior to sunitinib in all biomarker subsets for ccRCC #ASCO24
Proud of @MartinZarba for presenting this #IMDC study. More follow up and patients required but it does highlight the importance of VEGF inhibition in very favorable patients. They are the most sensitive. #hypothesisgenerating #ASCO24 @OncoAlert
The IMDC story continues with a new very favourable group (good risk with no visceral mets and 3yrs since surgery).All the pts did well but Ipi/nivo was least impressive. Modest numbers & patient selection confounding, but there are VEGF mono sensitive slow growing tumors #ASCO24
Dr. Zabra #IMDC analysis of #1L favorable/very favorable risk adv #RCC
No diff in OS among regimens in all favorable risk but better ORR w/VEGF-TKI+IO but worse OS and ORR w/nivo + ipi in very favorable risk disease
#ASCO24 @oncoalert
Great presentation by Martin Zarba discussing therapeutic options in pts with favorable and very favorable risk #mRCC from the #IMDC database!
@DrDanielHeng @TalalZarif1 @eddy_saad @KarlSemaan
@ASCO @Oncoalert #ASCO24
Great presentation by @ZarbaMartin1 at #ASCO24
A subgroup analysis of #IMDC of favorable and very favorable risk patients.
Still a #VEGF inhibitors are the pillar of treatment for this subgroup.
Come see our #IMDC fellow @Martinzarba Saturday 8am Room S100bc present on the Favorable risk and VERY favorable risk metastatic #kidneycancer population for potential guidance on therapy selection. #IMDConline @DrChoueiri @montypal @tompowles1 @ravikanesvaran @OncoAlert #ASCO24
Tom Powles on new @myESMO guidelines for renal cancer
@tompowles1
https://t.co/EsO4zLyXxT
#Cancer #BartsCancerCenter #Belzutifan #ESMO #IMDC #RenalCancer #OncoDaily #Oncology
I had the pleasure of meeting with Daniel Heng, the creator of the IMDC prognostic risk criteria for aRCC - Olubukola Ayodele
https://t.co/TVi8DrGZ4Q
#oncodaily #oncology #cancer #IMDC #prognosticcriteria #biomarkers #treatmentdecision #pathology #precisionmedicine
Last Seen Hashtags on Sotwe
大奶
Seen from United Kingdom
teenage()**************
Seen from Turkey
ควยนายแบบ
Seen from Thailand
الشيخه_سمو
Seen from Algeria
Gophercon
Seen from United States
nolimit()filter:media() - filter:images
Seen from Pakistan
Bbienestar
Seen from United States
スカトロ
Seen from Japan
รับงานหทัยราษฎร์
Seen from Thailand
นวดมีนบุรี
Seen from Thailand
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.7M followers
Taylor Swift
@taylorswift13
81.6M followers
Lady Gaga
@ladygaga
73.1M followers
Virat Kohli
@imvkohli
70M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.8M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.8M followers
X
@x
60.8M followers